The third part of our series focuses on the critical decisions that organizations face when commercializing their products and expanding their market presence. It specifically addresses the choice between launching a product independently or seeking strategic partnerships.
Participants learn more about:
- Key ingredients for commercial success for a biotech’s first launch, including quality of clinical evidence, engagement with key stakeholders, and robust P&MA strategy prior to launch
- Advantages and disadvantages of insourcing vs. outsourcing manufacturing and commercialization across key global geographies
By attending, participants will gain a comprehensive understanding of the factors influencing commercialization decisions, enabling them to make well-informed choices that align with their growth objectives.
This event is free of charge.